Tempest Therapeutics’ stock jumps 1,900% as liver-cancer treatment shows promise Markets – MarketWatch Posted on October 11, 2023 by The drug candidate showed clinical superiority as a first-line treatment for unresectable or metastatic hepatocellular carcinoma, a common type of liver cancer. Read More Markets – MarketWatch
Finance Bruising Treasury bond selloff is looking long in the tooth, says Deutsche Bank strategist Markets – MarketWatch October 10, 2023 0 A rout in Treasury bonds that has helped trample stocks and revive recession fears […]
Finance BioXcel Therapeutics Shares Rise 14% After Positive Trial Data for Cancer Treatment Markets – MarketWatch October 10, 2023 0 By Chris Wack BioXcel Therapeutics shares were up 14% to $3.13 after the company […]
Finance PepsiCo’s stock up premarket after earnings beat consensus and company raises guidance Markets – MarketWatch October 10, 2023 0 PepsiCo’s stock was up 1.8% premarket after an earnings beat. Read More Markets […]